EVP, Clinical Development · NovaBridge Biosciences · Ordinary Shares
Side
SELL
Value
$2,593
Shares
3,282
Price
$0.79
Executed
Aug 31, 2026
Disclosed
Sep 1, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 31 executedSep 1, 2026 disclosed
NBP · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Xu Cong Claire filed this Form 4 reporting a open-market sale of NBP on Aug 31, 2026. It became public on Sep 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP, Clinical Development
Xu Cong Clairecik:0002114309
Issuer
NovaBridge Biosciencescik:0001778016
Revision history · 0
No field has changed since this record was first ingested.
